Acquired Long QT Syndrome
A. John Camm, Marek Malík, Yee Guan Yap
Abstract
A. John Camm, Marek Malík, Yee Guan Yap
Abstract
Chapter 1. Introduction.Chapter 2. Mechanisms of Acquired QT Prolongation and Torsades de Pointes.Chapter 3. Measurement of QT Interval and Repolarization Assessment.Chapter 4: Introduction to Drug-Induced Long QT Syndrome.Chapter 5: Risk of QT Prolongation and Torsades de Pointes with Antiarrhythmic Drugs.Chapter 6: Risk of QT Prolongation and Torsades de Pointes with Antihistamines.Chapter 7: Risk of QT Prolongation and Torsades de Pointes with Psychotrophic Drugs.Chapter 8: Risk of QT Prolongation and Torsades de Pointes with Antimicrobial and Antimalarial Drugs.Chapter 9: Risk of QT Prolongation and Torsades de Pointes with Prokinetics and Miscellaneous.Chapter 10: Acquired Long QT Syndrome Secondary to Cardiac Conditions.Chapter 11: Acquired Long QT Syndrome Secondary to Noncardiac Conditions.Chapter 12: Preclinical and Clinical Assessment of the Risk of QT Prolongation and Torsades de Pointes with New Active Substances.Chapter 13: Conclusion and Perspective of Drug-Induced Repolarization Changes
OpenAlex reports 47 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Chapter 1. Introduction.Chapter 2. Mechanisms of Acquired QT Prolongation and Torsades de Pointes.Chapter 3. Measurement of QT Interval and Repolarization Assessment.Chapter 4: Introduction to Drug-Induced Long QT Syndrome.Chapter 5: Risk of QT Prolongation and Torsades de Pointes with Antiarrhythmic Drugs.Chapter 6: Risk of QT Prolongation and Torsades de Pointes with Antihistamines.Chapter 7: Risk of QT Prolongation and Torsades de Pointes with Psychotrophic Drugs.Chapter 8: Risk of QT Prolongation and Torsades de Pointes with Antimicrobial and Antimalarial Drugs.Chapter 9: Risk of QT Prolongation and Torsades de Pointes with Prokinetics and Miscellaneous.Chapter 10: Acquired Long QT Syndrome Secondary to Cardiac Conditions.Chapter 11: Acquired Long QT Syndrome Secondary to Noncardiac Conditions.Chapter 12: Preclinical and Clinical Assessment of the Risk of QT Prolongation and Torsades de Pointes with New Active Substances.Chapter 13: Conclusion and Perspective of Drug-Induced Repolarization Changes
Key concepts: Torsades de pointes, QT interval, Prolongation, Medicine, Long QT syndrome, Cardiology, Repolarization, Internal medicine